Evaluation of Central Sensitization, Fear-Avoidance, and Pain-Pressure Threshold With Chronic Pain After Hysterectomy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age21-80
SponsorKK Women's and Children's Hospital

About this trial

Phase 1 (started in July 2019):

Central Sensitization Inventory (CSI), Fear-Avoidance Components Scale (FACS), pain-pressure threshold are factors associated with chronic post-hysterectomy pain (CPHP), but a complete understanding on the development of CPHP is lacking. The study aims to identify clinically-relevant factors for CPHP that can be reliably assessed preoperatively.

===

Phase 2 (anticipated start May 2022):

In addition to above factors, the association between heart rate variability (HRV) parameters, anxiety level, anticipated pain, and anticipated analgesia requirement with significant postoperative pain and CPHP will be investigated.

Eligibility criteria

Qualifiers

Age 21 to 80 years old

American Society of Anesthesiologists Physical Scale (ASA) I to III

Benign gynaecological indications for hysterectomy

Elective abdominal or laparoscopic hysterectomy

Disqualifiers

Vaginal hysterectomy

Uterine prolapse, endometriosis, malignant disease, or pelvic pain as main indication for surgery

History of drug dependence or recreational drug use

History of chronic pain syndrome

Trial design

Treatments tested in this trial

  • Pain-Pressure Threshold
  • Mechanical Temporal Summation
  • Hospital Anxiety and Depression Scale
  • Pain Catastrophizing Scale
  • Central Sensitization Inventory
  • Fear-Avoidance Component Score
  • EQ-5D
  • heart rate variability
  • Anxiety, anticipated pain, anticipated analgesia
  • State-trait anxiety inventory
  • Beck's Depression Inventory

Treatment groups

436 Participants
are divided into 4 treatment groups